Completed
A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya®
NCT01705236
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Novartis Investigative Site Bochum, Germany
- Novartis Investigative Site Bonn, Germany
- Novartis Investigative Site Dresden, Germany
- Novartis Investigative Site Düsseldorf, Germany